Abstract

Fine-tuning of insulin release from pancreatic β-cells is essential to maintain blood glucose homeostasis. Here, we report that insulin secretion is regulated by a circular RNA containing the lariat sequence of the second intron of the insulin gene. Silencing of this intronic circular RNA in pancreatic islets leads to a decrease in the expression of key components of the secretory machinery of β-cells, resulting in impaired glucose- or KCl-induced insulin release and calcium signaling. The effect of the circular RNA is exerted at the transcriptional level and involves an interaction with the RNA-binding protein TAR DNA-binding protein 43 kDa (TDP-43). The level of this circularized intron is reduced in the islets of rodent diabetes models and of type 2 diabetic patients, possibly explaining their impaired secretory capacity. The study of this and other circular RNAs helps understanding β-cell dysfunction under diabetes conditions, and the etiology of this common metabolic disorder.

Circular RNAs contribute to the regulation of β-cell specific functions. Here the authors show that a circular RNA derived from one of the introns of the insulin gene is necessary for optimal insulin secretion from pancreatic islets and that its level is reduced in the islets of diabetic subjects.

Details

Title
A circular RNA generated from an intron of the insulin gene controls insulin secretion
Author
Stoll, Lisa 1   VIAFID ORCID Logo  ; Rodríguez-Trejo, Adriana 2 ; Guay Claudiane 2   VIAFID ORCID Logo  ; Brozzi Flora 2 ; Bayazit Mustafa Bilal 2 ; Gattesco Sonia 2 ; Menoud Véronique 2 ; Sobel, Jonathan 2 ; Marques, Ana Claudia 3 ; Venø Morten Trillingsgaard 4 ; Esguerra Jonathan Lou S 5   VIAFID ORCID Logo  ; Barghouth Mohammad 5 ; Suleiman, Mara 6 ; Marselli Lorella 6   VIAFID ORCID Logo  ; Kjems Jørgen 4 ; Eliasson Lena 5   VIAFID ORCID Logo  ; Renström, Erik 5   VIAFID ORCID Logo  ; Bouzakri Karim 7 ; Pinget Michel 7 ; Marchetti Piero 6 ; Regazzi Romano 8   VIAFID ORCID Logo 

 University of Lausanne, Department of Fundamental Neurosciences, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204); Department of Medicine, Weill Cornell Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 University of Lausanne, Department of Fundamental Neurosciences, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204) 
 University of Lausanne, Department of Computational Biology, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204) 
 Aarhus University, Interdisciplinary Nanoscience Center (iNANO) and Department of Molecular Biology and Genetics, Aarhus, Denmark (GRID:grid.7048.b) (ISNI:0000 0001 1956 2722) 
 Lund University, Islet Cell Exocytosis or Islet Pathophysiology Group, Lund University Diabetes Centre, Department of Clinical Sciences in Malmö, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729) 
 UMR DIATHEC, EA 7294, Centre Européen d’Etude du Diabète, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291) 
 University of Lausanne, Department of Fundamental Neurosciences, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204); University of Lausanne, Department of Biomedical Sciences, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471538269
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.